Gynecologic Oncology | Specialty

The OncLive Gynecologic Oncology condition center page is a comprehensive resource for clinical news and expert insights on various types of gynecologic cancers, including ovarian cancer, endometrial cancer, and uterine cancer, among others. This section features news articles, interviews with gynecologic oncologists in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in gynecologic cancers.

Conference Features Debates on Clinical Controversies

February 21st 2012

The 9th International Symposium on Ovarian Cancer and Other Gynecologic Malignancies conference will bring professionals in the field up to date on the latest research into ovarian, uterine, cervical, and endometrial cancers.

Dr. Birrer Discusses the GOG0218 and ICON7 Trials

February 2nd 2012

Dr. Michael Birrer, from Massachusetts General Hospital Cancer Center, Discusses the GOG0218 and ICON7 Trials

BRCA1 and BRCA2 Mutations Yield Better Prognosis in Ovarian Cancer Patients

January 25th 2012

Patients with ovarian cancer who express BRCA1/2 mutations demonstrated a better overall survival after 5 years.

Brain Metastasis Common in Ovarian Cancer

January 20th 2012

Half of all women with advanced ovarian cancer who develop brain cancer have a single metastasis to the brain.

Fertility Treatment Increases Risk of Ovarian Cancer

January 16th 2012

Subfertile women who undergo ovarian stimulation for in vitro fertilization have an increased risk of ovarian malignancies.

Planned Cooperative Group Merger Is Generating Concern

January 5th 2012

A proposed overhaul of the NCI's clinical trials system has created anxiety among gynecologic researchers who fear projects in women's cancer will be diminished in a scramble for funding with more common malignancies.

November 2011: Trials in Progress

December 6th 2011

This month's collection of trials in progress highlights trials presented at the 2011 American Society of Clinical Oncology Meeting.

HPV Vaccination Completion Rates Increase, but Gaps Remain

December 2nd 2011

New findings demonstrate a recent increase in the annual completion rates of vaccination against human papillomavirus (HPV) infection.

Dr. Woodruff on Oncofertility Insurance Coverage

November 2nd 2011

Dr. Teresa Woodruff from Feinberg School of Medicine, Northwestern University, Discusses Oncofertility Insurance Coverage

Dr. Mills Gives Examples of Unexpected Drug Responses

October 28th 2011

Dr. Gordon Mills from MD Anderson Cancer Center Gives Examples of Unexpected Therapy Responses

October 2011: Trials in Progress

October 21st 2011

This month's collection of trials in progress highlights trials presented at the 2011 American Society of Clinical Meeting.

5 Abstracts Among SGO Highlights

September 30th 2011

This report highlights 5 abstracts relevant to the current and future management of patients with female pelvic malignancies.

Triptorelin May Thwart Chemotherapy-Induced Early Menopause

September 29th 2011

Temporary ovarian suppression using triptorelin may decrease the rate of early menopause in premenopausal women with early-stage breast cancer undergoing adjuvant or neoadjuvant chemotherapy.

Taller Women May Be at Increased Risk of Cancer

September 28th 2011

British investigators are reporting that taller women have a higher risk of cancer, and that the link between height and cancer risk exists for most types of cancer.

Cancer Screening: Are You Recommending the Right Intervals?

September 22nd 2011

Now more than ever, oncology nurses need to be able to fill the knowledge gap and accurately educate their patients and the public about cancer screening tests and their frequency.

Exemestane Is a New Option for Prevention of Breast Cancer in Postmenopausal Women

August 1st 2011

Postmenopausal women at risk of breast cancer got good news from the MAP.3 trial results: Exemestane reduced their risk of invasive breast cancer by 65% compared with placebo.

Novel Agent Demonstrates Activity in Heavily Pretreated Ovarian Cancer That Progressed on Pegylated Doxorubicin

August 1st 2011

A novel topoisomerase-I inhibitor designated NKTR-102 demonstrated clinically significant activity as a single agent in patients with heavily pretreated ovarian cancer who failed prior PLD.

Sentinel Lymph Node Test Has No Effect on Overall Survival in Women With Early-Stage Breast Cancer

July 28th 2011

It had been thought that removing the sentinel node and the surrounding lymph nodes would improve survival rates.

Dr. Tripathy on Breast Cancer with Bone Metastases

July 16th 2011

Dr. Debu Tripathy from USC Norris Comprehensive Cancer Center on Breast Cancer with Bone Metastases

One-Carbon Nutrient Supplements May Boost Risk of Type II Endometrial Cancer

July 7th 2011

New data suggest that, contrary to expectation, the use of supplements containing one-carbon nutrients like folate and vitamins B2, B6, and B12 appears to be associated with an increased risk of type II endometrial cancer.